We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 12 JUNE 2015
D.C. Circuit Affirms: FTC Can Change HSR Rules Targeted At Pharmaceutical Patents

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Contributor

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Mintz is a litigation powerhouse and business accelerator serving leaders in life sciences, private...
View firm profileAlthough this decision specifically targets pharmaceutical deals, other industry deals are not in the clear.
United StatesIntellectual Property








